Sanofi-Aventis airs Ambien CR TV ads, coupon

Share this article:
Sanofi-Aventis' DTC campaign for Ambien CR (zolpidem tartrate extended release) began this month with a pair of television commercials--including a TV reminder ad--and a coupon for a free seven-day trial.
The 15-second reminder ad ran its course before Sanofi-Aventis introduced the longer spot, a spokesperson said. TV reminder ads are banned under the PhRMA DTC guidelines, which go into effect Jan. 1.
Among the scenes in the 60-second spot is one showing the multi-layered pill's first layer dissolving in a fizz of green 'Z's followed by the second only more slowly. That scene is followed by one of a woman waking up, looking well rested and vigorously going about her morning routine. A voiceover presents risk and safety information before the narrator concludes with the tagline, "Tomorrow will thank you."
The coupon, which ran in mixed media, offers a seven-day free trial of Ambien CR and appears to contain no indication or risk information.
Ambien CR gained approval in September, and Sanofi-Aventis launched to doctors in October.
Sanofi-Aventis, which faces patent expiration on original Ambien next year, aims to switch at least half of patients to the new formulation.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.